Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts.

Ann Hematol · 2026 · PMC13095964 · PMID 42010164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.055so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Similarly, the percentage of peripheral blood blasts showed a trend toward reduction, with a median of 19.5% (7.0–24.0) in TP53 -mutated AML versus 21.0% (16.0–26.0) in non-mutated AML, although the difference did not reach statistical significance ( p = 0.055) (see Supplementary Fig. 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.